Naveen Yalamanchi, Director, 10% Owner at ROCKET PHARMACEUTICALS, INC. (RCKT), bought 247,720 shares at $56.00 ($13.9M) on 2020-12-10, disclosed to the SEC on 2020-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |